.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Novartis
Fuji
Moodys
Express Scripts
Cantor Fitzgerald
Chinese Patent Office
Julphar
Baxter
US Department of Justice

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084530

« Back to Dashboard
NDA 084530 describes AMINOPHYLLINE, which is a drug marketed by Abraxis Pharm, Luitpold, Roxane, Hospira, Hikma Intl Pharms, King Pharms, Intl Medication, Vintage Pharms, Vangard, Ascot, Smith And Nephew, Vale, Lyphomed, Tablicaps, Pal Pak, Purepac Pharm, Elkins Sinn, Teva Parenteral, Panray, Morton Grove, Idt Australia Ltd, Valeant Pharm Intl, Watson Labs, Halsey, Impax Labs, Duramed Pharms Barr, Kv Pharm, Pharma Serve Ny, Lannett, Barr, and Actavis Mid Atlantic, and is included in fifty-nine NDAs. It is available from five suppliers. Additional details are available on the AMINOPHYLLINE profile page.

The generic ingredient in AMINOPHYLLINE is aminophylline. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aminophylline profile page.

Summary for NDA: 084530

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, DELAYED RELEASE;ORALStrength200MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Chinese Patent Office
Merck
Cantor Fitzgerald
Deloitte
Medtronic
AstraZeneca
Boehringer Ingelheim
Dow
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot